These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 28105369)
1. Potassium channels of T lymphocytes take center stage in the fight against cancer. Conforti L J Immunother Cancer; 2017; 5():2. PubMed ID: 28105369 [TBL] [Abstract][Full Text] [Related]
2. Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8 Mastelic-Gavillet B; Navarro Rodrigo B; Décombaz L; Wang H; Ercolano G; Ahmed R; Lozano LE; Ianaro A; Derré L; Valerio M; Tawadros T; Jichlinski P; Nguyen-Ngoc T; Speiser DE; Verdeil G; Gestermann N; Dormond O; Kandalaft L; Coukos G; Jandus C; Ménétrier-Caux C; Caux C; Ho PC; Romero P; Harari A; Vigano S J Immunother Cancer; 2019 Oct; 7(1):257. PubMed ID: 31601268 [TBL] [Abstract][Full Text] [Related]
3. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors. Balta E; Wabnitz GH; Samstag Y Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260 [TBL] [Abstract][Full Text] [Related]
4. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy. Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018 [TBL] [Abstract][Full Text] [Related]
5. Acquired resistance to cancer immunotherapy: Role of tumor-mediated immunosuppression. Saleh R; Elkord E Semin Cancer Biol; 2020 Oct; 65():13-27. PubMed ID: 31362073 [TBL] [Abstract][Full Text] [Related]
6. Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune Response. Reiser J; Banerjee A J Immunol Res; 2016; 2016():8941260. PubMed ID: 27314056 [TBL] [Abstract][Full Text] [Related]
10. A distinct innate lymphoid cell population regulates tumor-associated T cells. Crome SQ; Nguyen LT; Lopez-Verges S; Yang SY; Martin B; Yam JY; Johnson DJ; Nie J; Pniak M; Yen PH; Milea A; Sowamber R; Katz SR; Bernardini MQ; Clarke BA; Shaw PA; Lang PA; Berman HK; Pugh TJ; Lanier LL; Ohashi PS Nat Med; 2017 Mar; 23(3):368-375. PubMed ID: 28165478 [TBL] [Abstract][Full Text] [Related]
11. Animal models for studying tumor microenvironment (TME) and resistance to lymphocytic infiltration. Yamaguchi R; Perkins G Cancer Biol Ther; 2018; 19(9):745-754. PubMed ID: 29723108 [TBL] [Abstract][Full Text] [Related]
12. Metabolic Regulation of Tregs in Cancer: Opportunities for Immunotherapy. Wang H; Franco F; Ho PC Trends Cancer; 2017 Aug; 3(8):583-592. PubMed ID: 28780935 [TBL] [Abstract][Full Text] [Related]
13. Autocrine Complement Inhibits IL10-Dependent T-cell-Mediated Antitumor Immunity to Promote Tumor Progression. Wang Y; Sun SN; Liu Q; Yu YY; Guo J; Wang K; Xing BC; Zheng QF; Campa MJ; Patz EF; Li SY; He YW Cancer Discov; 2016 Sep; 6(9):1022-35. PubMed ID: 27297552 [TBL] [Abstract][Full Text] [Related]
15. Prognostic Landscape of Tumor-Infiltrating T and B Cells in Human Cancer. Zheng M; Li YM; Liu ZY; Zhang X; Zhou Y; Jiang JL; Zhu P; Yang XM; Tang J; Chen ZN Front Immunol; 2021; 12():731329. PubMed ID: 35069521 [TBL] [Abstract][Full Text] [Related]
16. Classifying Cancers Based on T-cell Infiltration and PD-L1. Teng MW; Ngiow SF; Ribas A; Smyth MJ Cancer Res; 2015 Jun; 75(11):2139-45. PubMed ID: 25977340 [TBL] [Abstract][Full Text] [Related]
17. Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing. Zhang L; Zhang Z Cancer Immunol Res; 2019 Jul; 7(7):1040-1046. PubMed ID: 31262773 [TBL] [Abstract][Full Text] [Related]
18. TGFβ1-Mediated SMAD3 Enhances PD-1 Expression on Antigen-Specific T Cells in Cancer. Park BV; Freeman ZT; Ghasemzadeh A; Chattergoon MA; Rutebemberwa A; Steigner J; Winter ME; Huynh TV; Sebald SM; Lee SJ; Pan F; Pardoll DM; Cox AL Cancer Discov; 2016 Dec; 6(12):1366-1381. PubMed ID: 27683557 [TBL] [Abstract][Full Text] [Related]
19. Intravenous injection of MVA virus targets CD8+ lymphocytes to tumors to control tumor growth upon combinatorial treatment with a TLR9 agonist. Fend L; Gatard-Scheikl T; Kintz J; Gantzer M; Schaedler E; Rittner K; Cochin S; Fournel S; Préville X Cancer Immunol Res; 2014 Dec; 2(12):1163-74. PubMed ID: 25168392 [TBL] [Abstract][Full Text] [Related]